Name: Image-Guided Biopsy Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: MI5826
Price: 4350 USD
Availability: InStock

Image-Guided Biopsy Market Size, Share, Growth and Report 2023-2030

Image-Guided Biopsy Market Size, Share, Industry, Forecast and outlook (2023-2030)

[180 Pages&nbsp;Report] Image-Guided Biopsy Market size was valued at US$ YY million in 2022&nbsp;and is estimated to reach US$ YY million by 2030, growing at a CAGR of 5.49 % during the forecast period (2023-2030).

Image-Guided Biopsy Market&nbsp;-&nbsp;Strategic Insights

<table border="1" cellpadding="1" cellspacing="1">
	<tbody>
		<tr>
			<td>
			Metrics
			</td>
			<td>
			Details
			</td>
		</tr>
		<tr>
			<td>
			Market&nbsp;CAGR
			</td>
			<td>
			5.49%
			</td>
		</tr>
		<tr>
			<td>
			Segments Covered
			</td>
			<td>
			By Technology, By Process,&nbsp;By Indication,&nbsp;By End-User&nbsp;and By Region
			</td>
		</tr>
		<tr>
			<td>
			Report Insights Covered
			</td>
			<td>
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
			</td>
		</tr>
		<tr>
			<td>
			Fastest Growing Region
			</td>
			<td>
			Asia Pacific
			</td>
		</tr>
		<tr>
			<td>
			Largest Market Share&nbsp;
			</td>
			<td>
			North America
			</td>
		</tr>
	</tbody>
</table>

To Get a Free Sample <a href="https://www.datamintelligence.com/download-sample/image-guided-biopsy-market">Click here</a>

Imaging technologies are used in image-guided biopsy to see inside the body. By positioning the needle in the ideal location during the biopsy, the medical professional can quickly get a sample of the problematic cell. It is recognized as one of the best collection techniques because it causes little harm. This method is frequently carried out in one of the two locations, such as the Interventional Radiology (IR) suite utilizing ultrasound (sound waves) or fluoroscopy (X-rays) or the CT room using a CT scanner, as photographs are needed to guide the placement of the needle during a biopsy.

Market Dynamics

Innovation in the Diagnostic Outcome of Image-Guided Percutaneous Core Needle Biopsy of Sclerotic Bone Lesions is expected to drive market growth.

The diagnostic yield of image-guided percutaneous CNB of sclerotic bone lesions has accuracy in estimating and differentiating benign from malignant lesions and shows very good results. Moreover, compared to the manual technique, the battery-powered bone biopsy device had a greater pooled fraction of the diagnostic output. For instance, numerous investigations found that sclerotic bone lesions had lower diagnostic yields than lytic bone lesions. Sclerotic lesions have substantially reduced tumor cellularity and reactive bone production. The manual drill mechanism is replaced with a battery-powered drill system to get around this restriction. This method is utilized for the aspiration and biopsy of bone marrow before being used for the biopsy of sclerotic bone lesions. The battery-powered drill device is found to have various benefits in these tests, including improved specimen size and quality and decreased process time, radiation dosage, and other factors. Therefore, considering these results, image-guided percutaneous CNB of sclerotic bone lesions is a reliable diagnostic method with a high diagnostic yield, especially when battery-powered bone biopsy equipment is employed. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

The increased concerns about the possibility of infections from aspiration and biopsy needles, the underdeveloped healthcare system, and the lack of skilled radiologists and oncologists are some factors the market is expected to get hampered in the forecast period.

Industry Analysis

The image-guided biopsy market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, reimbursement scenario, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. To preserve personal protective equipment (PPE), increase hospital capacity and safeguard patients in need of non-urgent surgery and other operations from virus infection in the hospital setting, elective medical treatments have been postponed in the United States. Scheduling templates should emphasize radiologic examination of high-risk women using mammography and MRI above screening for low-risk patients. Moreover, patients are examined for COVID-19 symptoms and tested if a disease is suspected if she requires an image-guided biopsy. If the biopsy results are positive, it is postponed as much as possible to protect staff and other patients from exposure and to prevent complicating the patient&#39;s COVID-19 condition. An image-guided biopsy can be performed if there are no symptoms or indicators of COVID-19 or if the test results in a negative result. To safeguard patients and staff, radiology facilities implemented measures comparable to those mentioned above before reintroducing screening tests and image-guided biopsies.

Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

MRI segment is expected to hold the largest market share in image-guided biopsy market

The MRI segment is expected to dominate in 2021. The segment benefits because the technique can be finished within one hour and is less invasive than surgical biopsy. It also leaves little to no scars. Radiation-free imaging is possible with MRI, a non-invasive imaging method. An MRI-guided breast biopsy is quicker, less invasive, and less expensive than a surgical biopsy. Patients can quickly resume their regular activities after recovery. Moreover, ionizing radiation is not used during MRI-guided biopsy. Using either the vacuum-assisted device or the core needle technique. Therefore, it has increased the demand for MRI image-guided biopsy. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global image-guided biopsy market

In 2021, North America accounted for the highest revenue share. The rising geriatric population, the increasing prevalence of cancer, enhanced healthcare infrastructure, increased investment, rising healthcare costs, product launches and acquisitions by the market players are some factors the market is expected to boost in the forecast period. For instance, 1,752,735 new cancer cases were reported in the United States in 2019, while 599,589 people died from the disease. Four hundred thirty-nine new cases of cancer and 146 cancer-related deaths were reported for every 100,000 persons. In contrast, in the US, 1,806,590 new cancer cases and 606,520 cancer-related deaths are anticipated in 2020, or 4,950 new cases and more than 1,600 fatalities daily. Therefore, by taking out and studying a sample of the relevant tissue or fluid, aspiration and biopsy are frequently used to investigate the nature of malignancies. Image-guided biopsy demand is rising due to government and medical organizations stepping up efforts to provide improved diagnostic services in response to the rising cancer incidence.

In addition, Cook Medical&#39;s breast localization needle and soft tissue biopsy product lines were bought by IZI Medical Products in January 2019. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the image-guided biopsy market are Koninklijke Philips N.V, Siemens Healthcare GmbH, GE Healthcare, Brainlab, Medtronic, Olympus Corporation, Stryker, Hologic Inc.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

GE Healthcare:

Overview:

GE Healthcare is a subsidiary of American multinational conglomerate General Electric Company. The company manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures as of 2017. Dyes for magnetic-resonance imaging methods are available from the firm. GE Healthcare also manufactures medical diagnostic equipment, including CT image machines. Moreover, it develops Health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. The company is operated in more than 100 countries.

&shy;Product Portfolio:

CT-Guided Biopsy: A biopsy method locates an abnormal body area using a CT scan, a specialized sort of x-ray connected to a computer. It uses that location to help guide the removal of a tissue sample. Typically, a needle retrieved the sample and examined for illness indicators under a microscope.

The global image-guided biopsy market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">FAQ</h3>

What is the Image-Guided Biopsy Market growth?

The market is growing at a CAGR&nbsp;of 5.49%

What is Image-Guided Biopsy Market size in 2022?

The&nbsp;Image-Guided Biopsy Market size was valued at USD YY million in 2022.

Who are the key players in Image-Guided Biopsy Market?

Koninklijke Philips N.V, Siemens Healthcare GmbH, GE Healthcare, Brainlab, Medtronic.

<ol>
	<li>Methodology and Scope
	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>Market Definition and Overview</li>
	<li>Executive Summary</li>
	<li>Market Dynamics
	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Innovation in the Diagnostic Outcome of Image-Guided Percutaneous Core Needle Biopsy of Sclerotic Bone Lesions is expected to drive market growth.</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>Lack of skilled radiologists and oncologists is expected to hamper the market growth.</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Industry Analysis
	<ol>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Unmet Needs</li>
		<li>Pipeline Analysis</li>
	</ol>
	</li>
	<li>COVID-19 Analysis
	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>By Technology
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Attractiveness Index, By Technology Segment</li>
		</ol>
		</li>
		<li>X- Ray*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li>
		</ol>
		</li>
		<li>Ultrasound</li>
		<li>Mammography</li>
		<li>CT</li>
		<li>MRI</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By Process
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Process</li>
			<li>Market Attractiveness Index, By Process Segment</li>
		</ol>
		</li>
		<li>Fine Needle*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li>
		</ol>
		</li>
		<li>Core Needle</li>
		<li>Vacuum- Assisted Biopsy</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By Indication
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Attractiveness Index, By Indication Segment</li>
		</ol>
		</li>
		<li>Cancer*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li>
		</ol>
		</li>
		<li>Liver Disease</li>
		<li>Kidney Disease</li>
		<li>Infectious Diseases</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By End-user
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li>
			<li>Market Attractiveness Index, By End user Segment</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li>
		</ol>
		</li>
		<li>Diagnostic Centers</li>
		<li>Ambulatory Surgery Centers</li>
		<li>Research Institutes</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By Region
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Process</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Process</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Process</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Process</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Process</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Sales</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Competitive Landscape
	<ol>
		<li>Key Developments and Strategies</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
		<li>List of Key Companies to Watch</li>
	</ol>
	</li>
	<li>Company Profiles
	<ol>
		<li>Koninklijke Philips N.V*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview &nbsp;</li>
		</ol>
		</li>
		<li>Siemens Healthcare GmbH&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>GE Healthcare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Brainlab&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Medtronic&nbsp;&nbsp;</li>
		<li>Olympus Corporation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Stryker&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Hologic Inc. (*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>DataM Intelligence
	<ol>
		<li>Appendix</li>
		<li>About Us and Applications</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table1 Global Image-Guided Biopsy Market Value, By Technology, 2021, 2025 &amp; 2029 ($ Million)

Table2 Global Image-Guided Biopsy Market Value, By Process, 2021, 2025 &amp; 2029 ($ Million)

Table3 Global Image-Guided Biopsy Market Value, By Indication, 2021, 2025 &amp; 2029 ($ Million)

Table4 Global Image-Guided Biopsy Market Value, By End user, 2021, 2025 &amp; 2029 ($ Million)

Table5 Global Image-Guided Biopsy Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table6 Global Image-Guided Biopsy Market Value, By Technology, 2021, 2025 &amp; 2029 ($ Million)

Table7 Global Image-Guided Biopsy Market Value, By Technology, 2020-2029 ($ Million)

Table8 Global Image-Guided Biopsy Market Value, By Process, 2021, 2025 &amp; 2029 ($ Million)

Table9 Global Image-Guided Biopsy Market Value, By Process, 2020-2029 ($ Million)

Table10 Global Image-Guided Biopsy Market Value, By Indication, 2021, 2025 &amp; 2029 ($ Million)

Table11 Global Image-Guided Biopsy Market Value, By Indication, 2020-2029 ($ Million)

Table12 Global Image-Guided Biopsy Market Value, By End user, 2021, 2025 &amp; 2029 ($ Million)

Table13 Global Image-Guided Biopsy Market Value, By End user, 2020-2029 ($ Million)

Table14 Global Image-Guided Biopsy Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table15 Global Image-Guided Biopsy Market Value, By Region, 2020-2029 ($ Million)

Table16 North America Image-Guided Biopsy Market Value, By Technology, 2020-2029 ($ Million)

Table17 North America Image-Guided Biopsy Market Value, By Process, 2020-2029 ($ Million)

Table18 North America Image-Guided Biopsy Market Value, By Indication, 2020-2029 ($ Million)

Table19 North America Image-Guided Biopsy Market Value, By End user, 2020-2029 ($ Million)

Table20 North America Image-Guided Biopsy Market Value, By Country, 2020-2029 ($ Million)

Table21 South America Image-Guided Biopsy Market Value, By Technology, 2020-2029 ($ Million)

Table22 South America Image-Guided Biopsy Market Value, By Process, 2020-2029 ($ Million)

Table23 South America Image-Guided Biopsy Market Value, By Indication, 2020-2029 ($ Million)

Table24 South America Image-Guided Biopsy Market Value, By End user, 2020-2029 ($ Million)

Table25 South America Image-Guided Biopsy Market Value, By Country, 2020-2029 ($ Million)

Table26 Europe Image-Guided Biopsy Market Value, By Technology, 2020-2029 ($ Million)

Table27 Europe Image-Guided Biopsy Market Value, By Process, 2020-2029 ($ Million)

Table28 Europe Image-Guided Biopsy Market Value, By Indication, 2020-2029 ($ Million)

Table29 Europe Image-Guided Biopsy Market Value, By End user, 2020-2029 ($ Million)

Table30 Europe Image-Guided Biopsy Market Value, By Country, 2020-2029 ($ Million)

Table31 Asia-Pacific Image-Guided Biopsy Market Value, By Technology, 2020-2029 ($ Million)

Table32 Asia-Pacific Image-Guided Biopsy Market Value, By Process, 2020-2029 ($ Million)

Table33 Asia-Pacific Image-Guided Biopsy Market Value, By Indication, 2020-2029 ($ Million)

Table34 Asia-Pacific Image-Guided Biopsy Market Value, By End user, 2020-2029 ($ Million)

Table35 Asia-Pacific Image-Guided Biopsy Market Value, By Country, 2020-2029 ($ Million)

Table36 Middle East &amp; Africa Image-Guided Biopsy Market Value, By Technology, 2020-2029 ($ Million)

Table37 Middle East &amp; Africa Image-Guided Biopsy Market Value, By Process, 2020-2029 ($ Million)

Table38 Middle East &amp; Africa Image-Guided Biopsy Market Value, By Indication, 2020-2029 ($ Million)

Table39 Middle East &amp; Africa Image-Guided Biopsy Market Value, By End user, 2020-2029 ($ Million)

Table40 Koninklijke Philips N.V: Overview

Table41 Koninklijke Philips N.V: Product Portfolio

Table42 Koninklijke Philips N.V: Key Developments

Table43 Siemens Healthcare GmbH: Overview

Table44 Siemens Healthcare GmbH: Product Portfolio

Table45 Siemens Healthcare GmbH: Key Developments

Table46 GE Healthcare: Overview

Table47 GE Healthcare: Product Portfolio

Table48 GE Healthcare: Key Developments

Table49 Brainlab: Overview

Table50 Brainlab: Product Portfolio

Table51 Brainlab: Key Developments

Table52 Medtronic: Overview

Table53 Medtronic: Product Portfolio

Table54 Medtronic: Key Developments

Table55 Olympus Corporation: Overview

Table56 Olympus Corporation: Product Portfolio

Table57 Olympus Corporation: Key Developments

Table58 Stryker: Overview

Table59 Stryker: Product Portfolio

Table60 Stryker: Key Developments

Table61 Hologic Inc.: Overview

Table62 Hologic Inc.: Product Portfolio

Table63 Hologic Inc.: Key Developments

List of Figures

Figure1 Global Image-Guided Biopsy Market Share, By Technology, 2020 &amp; 2029 (%)

Figure2 Global Image-Guided Biopsy Market Share, By Process, 2020 &amp; 2029 (%)

Figure3 Global Image-Guided Biopsy Market Share, By Indication, 2020 &amp; 2029 (%)

Figure4 Global Image-Guided Biopsy Market Share, By End user, 2020 &amp; 2029 (%)

Figure5 Global Image-Guided Biopsy Market Share, By Region, 2020 &amp; 2029 (%)

Figure6 Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure7 Global Image-Guided Biopsy Market Y-o-Y Growth, By Technology, 2020-2028 (%)

Figure8 X- Ray: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure9 Ultrasound: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure10 Mammography: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure11 CT: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure12 MRI: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure13 Others: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure14 Global Image-Guided Biopsy Market Y-o-Y Growth, By Process, 2020-2028 (%)

Figure15 Fine Needle: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure16 Core Needle: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure17 Vacuum- Assisted Biopsy: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure18 Others: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure19 Global Image-Guided Biopsy Market Y-o-Y Growth, By Indication, 2020-2028 (%)

Figure20 Cancer: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure21 Liver Disease: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure22 Kidney Disease: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure23 Infectious Diseases: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure24 Others: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure25 Global Image-Guided Biopsy Market Y-o-Y Growth, By End user, 2020-2028 (%)

Figure26 Hospitals: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure27 Diagnostic Centers: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure28 Ambulatory Surgery Centers: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure29 Research Institutes: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure30 Others: Global Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure31 Global Image-Guided Biopsy Market Y-o-Y Growth, By Region, 2020-2028 (%)

Figure32 North America Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure33 North America Image-Guided Biopsy Market Share, By Technology, 2020 &amp; 2029 (%)

Figure34 North America Image-Guided Biopsy Market Share, By Process, 2020 &amp; 2029 (%)

Figure35 North America Image-Guided Biopsy Market Share, By Indication, 2020 &amp; 2029 (%)

Figure36 North America Image-Guided Biopsy Market Share, By End user, 2020 &amp; 2029 (%)

Figure37 North America Image-Guided Biopsy Market Share, By Country, 2020 &amp; 2029 (%)

Figure38 South America Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure39 South America Image-Guided Biopsy Market Share, By Technology, 2020 &amp; 2029 (%)

Figure40 South America Image-Guided Biopsy Market Share, By Process, 2020 &amp; 2029 (%)

Figure41 South America Image-Guided Biopsy Market Share, By Indication, 2020 &amp; 2029 (%)

Figure42 South America Image-Guided Biopsy Market Share, By End user, 2020 &amp; 2029 (%)

Figure43 South America Image-Guided Biopsy Market Share, By Country, 2020 &amp; 2029 (%)

Figure44 Europe Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure45 Europe Image-Guided Biopsy Market Share, By Technology, 2020 &amp; 2029 (%)

Figure46 Europe Image-Guided Biopsy Market Share, By Process, 2020 &amp; 2029 (%)

Figure47 Europe Image-Guided Biopsy Market Share, By Indication, 2020 &amp; 2029 (%)

Figure48 Europe Image-Guided Biopsy Market Share, By End user, 2020 &amp; 2029 (%)

Figure49 Europe Image-Guided Biopsy Market Share, By Country, 2020 &amp; 2029 (%)

Figure50 Asia-Pacific Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure51 Asia-Pacific Image-Guided Biopsy Market Share, By Technology, 2020 &amp; 2029 (%)

Figure52 Asia-Pacific Image-Guided Biopsy Market Share, By Process, 2020 &amp; 2029 (%)

Figure53 Asia-Pacific Image-Guided Biopsy Market Share, By Indication, 2020 &amp; 2029 (%)

Figure54 Asia-Pacific Image-Guided Biopsy Market Share, By End user, 2020 &amp; 2029 (%)

Figure55 Asia-Pacific Image-Guided Biopsy Market Share, By Country, 2020 &amp; 2029 (%)

Figure56 Middle East &amp; Africa Image-Guided Biopsy Market Value, 2020-2029 ($ Million)

Figure57 Middle East &amp; Africa Image-Guided Biopsy Market Share, By Technology, 2020 &amp; 2029 (%)

Figure58 Middle East &amp; Africa Image-Guided Biopsy Market Share, By Process, 2020 &amp; 2029 (%)

Figure59 Middle East &amp; Africa Image-Guided Biopsy Market Share, By Indication, 2020 &amp; 2029 (%)

Figure60 Middle East &amp; Africa Image-Guided Biopsy Market Share, By End user, 2020 &amp; 2029 (%)

Figure61 Koninklijke Philips N.V: Financials

Figure62 Siemens Healthcare GmbH: Financials

Figure63 GE Healthcare: Financials

Figure64 Brainlab: Financials

Figure65 Medtronic: Financials

Figure66 Olympus Corporation: Financials

Figure67 Stryker: Financials

Figure68 Hologic Inc.: Financials